Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria.
Magerl M, Rother M, Bieber T, Biedermann T, Brasch J, Dominicus R, Hunzelmann N, Jakob T, Mahler V, Popp G, Schäkel K, Schlingensiepen R, Schmitt J, Siebenhaar F, Simon JC, Staubach P, Wedi B, Weidner C, Maurer M.
Magerl M, et al. Among authors: brasch j.
J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e363-9. doi: 10.1111/j.1468-3083.2012.04689.x. Epub 2012 Aug 29.
J Eur Acad Dermatol Venereol. 2013.
PMID: 22928719
Clinical Trial.